Stock listing

BM8 Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.

Selected listing: BM8 · BX · CHF · CH

The BM8:BX listing represents BioMarin Pharmaceutical Inc., a company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. BioMarin is known for its commitment to advancing therapies for rare genetic disorders and has a robust pipeline of products in various stages of development. Recent news includes updates on clinical trials and regulatory filings that highlight the company's ongoing efforts to bring new treatments to market. Investors can stay informed about upcoming events and market developments that may impact BioMarin's growth and performance.

BM8:BXCHFCHUpdated July 20, 2026
Biomarin Pharmaceutical Inc. logo
Ticker
BM8:BX
Asset type
Stock
Market cap
$11.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
BX
Currency
CHF

Biomarin Pharmaceutical Inc. BM8:BX stock context

The BM8:BX listing represents BioMarin Pharmaceutical Inc., a company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. BioMarin is known for its commitment to advancing therapies for rare genetic disorders and has a robust pipeline of products in various stages of development. Recent news includes updates on clinical trials and regulatory filings that highlight the company's ongoing efforts to bring new treatments to market. Investors can stay informed about upcoming events and market developments that may impact BioMarin's growth and performance.

Research Biomarin Pharmaceutical Inc.

Alternate listings